|
||
J. Exp. Med.,
Volume 186, Number 10, November 17, 1997 1769-1774
/
Stimulated by Nonpeptidic Ligands
By

From * Experimental Immunology, Department of Research, University Hospital, CH-4031 Basel,
Switzerland; and Killer cell inhibitory receptors and CD94-NKG2-A/B heterodimers are major histocompatibility complex class I-specific inhibitory receptors expressed by natural killer cells, T cell antigen receptor (TCR)-
Basel Institute for Immunology, CH-4005 Basel, Switzerland
/
cells, and a subset of TCR-
/
cells. We studied the functional interaction between TCR-
/
and CD94, this inhibitory receptor being expressed on the
majority of
/
T cells. When engaged by human histocompatibility leukocyte antigen class I molecules, CD94 downmodulates activation of human TCR-
/
by phosphorylated ligands.
CD94-mediated inhibition is more effective at low than at high doses of TCR ligand, which
may focus T cell responses towards antigen-presenting cells presenting high amounts of antigen. CD94 engagement has major effects on TCR signaling cascade. It facilitates recruitment
of SHP-1 phosphatase to TCR-CD3 complex and affects phosphorylation of Lck and ZAP-70
kinase, but not of CD3
chain upon TCR triggering. These events may cause abortion of
proximal TCR-mediated signaling and set a higher TCR activation threshold.
This article has been cited by other articles:
| TABLE OF CONTENTS |
|